Extended sensitivity for PK/PD and biomarker analysis using nanoliter-scale immunoassays
In this webinar presented on February 23, 2021 at the SelectScience Analytical Summit, Chris Fox introduces the extension of the microfluidic, nanoliter-scale Gyrolab® immunoassay platform sensitivity for PK and biomarker assays.
Discovery and development of biotherapeutics requires robust immunoassays for quantification to support pharmacokinetic (PK) studies, as well as biomarker analysis. A microfluidic, flow-through platform with high reproducibility has extended assay sensitivity capabilities with a new CD consumable, the Gyrolab Bioaffy™ 4000 CD. Data demonstrating the improvement of assay dynamic range for PK and biomarker analysis will be presented, along with a novel approach to cytokine biomarker panel assay design.